Go Pro

Sotera Health (SHC) Competitors

Sotera Health logo
$18.02 +0.03 (+0.14%)
As of 03:41 PM Eastern
This is a fair market value price provided by Massive. Learn more.

SHC vs. GH, BTSG, FMS, PACS, and HIMS

Should you buy Sotera Health stock or one of its competitors? MarketBeat compares Sotera Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sotera Health include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), PACS Group (PACS), and Hims & Hers Health (HIMS).

How does Sotera Health compare to Guardant Health?

Sotera Health (NASDAQ:SHC) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

Sotera Health has a net margin of 9.91% compared to Guardant Health's net margin of -38.33%. Sotera Health's return on equity of 39.73% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
Guardant Health -38.33%N/A -25.40%

Sotera Health has a beta of 1.77, meaning that its share price is 77% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market.

In the previous week, Guardant Health had 29 more articles in the media than Sotera Health. MarketBeat recorded 38 mentions for Guardant Health and 9 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.32 beat Guardant Health's score of 0.93 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Guardant Health
18 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

91.0% of Sotera Health shares are owned by institutional investors. Comparatively, 92.6% of Guardant Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 5.6% of Guardant Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Sotera Health has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B4.41$77.94M$0.4143.94
Guardant Health$982.02M21.85-$416.28M-$3.49N/A

Sotera Health presently has a consensus price target of $20.25, suggesting a potential upside of 12.41%. Guardant Health has a consensus price target of $183.78, suggesting a potential upside of 14.93%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Sotera Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
23 Buy rating(s)
1 Strong Buy rating(s)
2.96

Summary

Sotera Health beats Guardant Health on 10 of the 17 factors compared between the two stocks.

How does Sotera Health compare to BrightSpring Health Services?

Sotera Health (NASDAQ:SHC) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, media sentiment, dividends, analyst recommendations, valuation, risk and profitability.

Sotera Health currently has a consensus target price of $20.25, suggesting a potential upside of 12.41%. BrightSpring Health Services has a consensus target price of $70.71, suggesting a potential upside of 11.42%. Given Sotera Health's higher probable upside, analysts plainly believe Sotera Health is more favorable than BrightSpring Health Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
3.00

Sotera Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

BrightSpring Health Services has higher revenue and earnings than Sotera Health. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B4.41$77.94M$0.4143.94
BrightSpring Health Services$12.91B0.97$190.67M$1.6638.23

Sotera Health has a net margin of 9.91% compared to BrightSpring Health Services' net margin of 2.55%. Sotera Health's return on equity of 39.73% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
BrightSpring Health Services 2.55%16.73%5.24%

In the previous week, BrightSpring Health Services had 13 more articles in the media than Sotera Health. MarketBeat recorded 22 mentions for BrightSpring Health Services and 9 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.32 beat BrightSpring Health Services' score of 0.80 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
7 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Sotera Health beats BrightSpring Health Services on 9 of the 17 factors compared between the two stocks.

How does Sotera Health compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Sotera Health (NASDAQ:SHC) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, earnings, risk, media sentiment, valuation, analyst recommendations and institutional ownership.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, meaning that its stock price is 23% less volatile than the broader market. Comparatively, Sotera Health has a beta of 1.77, meaning that its stock price is 77% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $23.95, indicating a potential downside of 0.40%. Sotera Health has a consensus price target of $20.25, indicating a potential upside of 12.41%. Given Sotera Health's stronger consensus rating and higher possible upside, analysts plainly believe Sotera Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73

Sotera Health has a net margin of 9.91% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.88%. Sotera Health's return on equity of 39.73% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Sotera Health 9.91%39.73%7.05%

In the previous week, Fresenius Medical Care AG & Co. KGaA had 4 more articles in the media than Sotera Health. MarketBeat recorded 13 mentions for Fresenius Medical Care AG & Co. KGaA and 9 mentions for Sotera Health. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.86 beat Sotera Health's score of 1.32 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Sotera Health
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Sotera Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.66
Sotera Health$1.16B4.41$77.94M$0.4143.94

Summary

Sotera Health beats Fresenius Medical Care AG & Co. KGaA on 11 of the 16 factors compared between the two stocks.

How does Sotera Health compare to PACS Group?

Sotera Health (NASDAQ:SHC) and PACS Group (NYSE:PACS) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Sotera Health has a beta of 1.77, suggesting that its share price is 77% more volatile than the broader market. Comparatively, PACS Group has a beta of -0.08, suggesting that its share price is 108% less volatile than the broader market.

PACS Group has higher revenue and earnings than Sotera Health. PACS Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B4.41$77.94M$0.4143.94
PACS Group$5.29B1.36$191.54M$1.5629.13

In the previous week, Sotera Health had 1 more articles in the media than PACS Group. MarketBeat recorded 9 mentions for Sotera Health and 8 mentions for PACS Group. Sotera Health's average media sentiment score of 1.32 beat PACS Group's score of 1.20 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PACS Group
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Sotera Health has a net margin of 9.91% compared to PACS Group's net margin of 4.49%. Sotera Health's return on equity of 39.73% beat PACS Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
PACS Group 4.49%26.47%4.36%

Sotera Health currently has a consensus price target of $20.25, suggesting a potential upside of 12.41%. PACS Group has a consensus price target of $50.60, suggesting a potential upside of 11.37%. Given Sotera Health's stronger consensus rating and higher possible upside, equities analysts plainly believe Sotera Health is more favorable than PACS Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by company insiders. Comparatively, 70.1% of PACS Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

Sotera Health beats PACS Group on 12 of the 16 factors compared between the two stocks.

How does Sotera Health compare to Hims & Hers Health?

Sotera Health (NASDAQ:SHC) and Hims & Hers Health (NYSE:HIMS) are both mid-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, earnings, institutional ownership, profitability, valuation and risk.

91.0% of Sotera Health shares are held by institutional investors. Comparatively, 63.5% of Hims & Hers Health shares are held by institutional investors. 15.4% of Sotera Health shares are held by insiders. Comparatively, 11.8% of Hims & Hers Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Hims & Hers Health had 18 more articles in the media than Sotera Health. MarketBeat recorded 27 mentions for Hims & Hers Health and 9 mentions for Sotera Health. Sotera Health's average media sentiment score of 1.32 beat Hims & Hers Health's score of 0.24 indicating that Sotera Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Sotera Health
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hims & Hers Health
4 Very Positive mention(s)
3 Positive mention(s)
12 Neutral mention(s)
5 Negative mention(s)
3 Very Negative mention(s)
Neutral

Sotera Health has a net margin of 9.91% compared to Hims & Hers Health's net margin of -0.56%. Sotera Health's return on equity of 39.73% beat Hims & Hers Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Sotera Health9.91% 39.73% 7.05%
Hims & Hers Health -0.56%6.10%1.52%

Hims & Hers Health has higher revenue and earnings than Sotera Health. Hims & Hers Health is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sotera Health$1.16B4.41$77.94M$0.4143.94
Hims & Hers Health$2.35B3.17$128.37M-$0.09N/A

Sotera Health has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, Hims & Hers Health has a beta of 2.4, indicating that its stock price is 140% more volatile than the broader market.

Sotera Health currently has a consensus target price of $20.25, suggesting a potential upside of 12.41%. Hims & Hers Health has a consensus target price of $31.43, suggesting a potential downside of 2.23%. Given Sotera Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Sotera Health is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Sotera Health
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
0 Strong Buy rating(s)
2.73
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19

Summary

Sotera Health beats Hims & Hers Health on 12 of the 16 factors compared between the two stocks.

Get Sotera Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for SHC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SHC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SHC vs. The Competition

MetricSotera HealthLife Sciences Tools & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$5.12B$9.06B$6.79B$13.03B
Dividend YieldN/A1.47%2.60%10.03%
P/E Ratio43.8159.12279.7125.52
Price / Sales4.41105.77649.11116.03
Price / Cash13.9825.6328.6434.82
Price / Book8.465.1411.166.36
Net Income$77.94M$57.47B$3.48B$347.60M
7 Day Performance1.44%1.05%2.55%3.18%
1 Month Performance0.47%-2.43%-2.76%-2.03%
1 Year Performance59.71%15.67%64.39%21.31%

Sotera Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SHC
Sotera Health
3.5783 of 5 stars
$18.02
+0.1%
$20.25
+12.4%
+61.3%$5.12B$1.16B43.813,000
GH
Guardant Health
3.3966 of 5 stars
$143.98
-1.0%
$160.04
+11.2%
+283.5%$19.09B$1.08BN/A2,506
BTSG
BrightSpring Health Services
4.8414 of 5 stars
$72.33
+0.5%
$70.12
-3.1%
+207.9%$14.27B$13.65B51.2923,500
FMS
Fresenius Medical Care AG & Co. KGaA
3.9085 of 5 stars
$24.73
-0.6%
$23.95
-3.1%
+1.0%$13.28B$22.20B13.011,488
PACS
PACS Group
3.7659 of 5 stars
$47.12
+0.1%
$50.60
+7.4%
+320.1%$7.45B$5.43B30.1947,455

Related Companies and Tools


This page (NASDAQ:SHC) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners